Publicacions en què col·labora amb Fernando Soler Pardo (7)

2023

  1. Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axis

    Molecular Therapy - Nucleic Acids, Vol. 32, pp. 704-720

2022

  1. Critical warm ischemia time point for cardiac donation after circulatory death

    American Journal of Transplantation, Vol. 22, Núm. 5, pp. 1321-1328

2021

  1. The miRNA199a/SIRT1/P300/Yy1/sST2 signaling axis regulates adverse cardiac remodeling following MI

    Scientific Reports, Vol. 11, Núm. 1

2017

  1. Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes

    PLoS ONE, Vol. 12, Núm. 2

2016

  1. Early oxidative damage induced by doxorubicin: Source of production, protection by GKT137831 and effect on Ca2+ transporters in HL-1 cardiomyocytes

    Archives of Biochemistry and Biophysics, Vol. 594, pp. 26-36

2012

  1. Inhibition of the intracellular Ca2+ transporter SERCA (Sarco-endoplasmic Reticulum Ca2+-ATPase) by the natural polyphenol epigallocatechin-3-gallate

    Journal of Bioenergetics and Biomembranes, Vol. 44, Núm. 5, pp. 597-605

2011

  1. Passive Ca2+ overload in H9c2 cardiac myoblasts: Assessment of cellular damage and cytosolic Ca2+ transients

    Archives of Biochemistry and Biophysics, Vol. 512, Núm. 2, pp. 175-182